Production (Stage)
Avalo Therapeutics, Inc.
AVTX
$3.75
-$0.16-4.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 125.05M | 134.55M | 81.86M | 93.43M | 110.18M |
| Total Receivables | -- | 611.00K | 998.00K | 33.00K | 35.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.83M | 3.71M | 3.25M | 2.44M | 997.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 62.00K | 19.00K | 41.00K | -- | 4.00K |
| Total Current Assets | 126.94M | 138.89M | 86.15M | 95.89M | 111.21M |
|
|
|||||
| Total Current Assets | 126.94M | 138.89M | 86.15M | 95.89M | 111.21M |
| Net Property, Plant & Equipment | 949.00K | 1.21M | 1.67M | 1.78M | 1.88M |
| Long-term Investments | 10.50M | 10.50M | 10.50M | 10.50M | 10.50M |
| Goodwill | 10.50M | 10.50M | 10.50M | 10.50M | 10.50M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 131.00K | 131.00K | 131.00K | 131.00K | 131.00K |
| Total Assets | 138.52M | 150.73M | 98.46M | 108.31M | 123.73M |
|
|
|||||
| Total Accounts Payable | 681.00K | 283.00K | 1.81M | 654.00K | 916.00K |
| Total Accrued Expenses | 3.69M | 5.22M | 3.59M | 3.72M | 3.02M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 526.00K | 568.00K | 550.00K | 548.00K | 545.00K |
| Total Finance Division Other Current Liabilities | 719.00K | 894.00K | 54.72M | 91.47M | 211.22M |
| Total Other Current Liabilities | 719.00K | 894.00K | 54.72M | 91.47M | 211.22M |
| Total Current Liabilities | 5.62M | 6.96M | 60.67M | 96.40M | 215.70M |
|
|
|||||
| Total Current Liabilities | 5.62M | 6.96M | 60.67M | 96.40M | 215.70M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 275.00K | 350.00K | 1.08M | 1.18M | 1.28M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 10.02M | 10.39M | 13.96M | 12.88M | 7.83M |
| Total Liabilities | 15.91M | 17.70M | 75.72M | 110.46M | 224.81M |
|
|
|||||
| Common Stock & APIC | 506.03M | 503.30M | 356.00M | 344.35M | 343.88M |
| Retained Earnings | -383.41M | -370.26M | -334.92M | -357.96M | -456.42M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 122.62M | 133.03M | 21.08M | -13.61M | -112.54M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | 1.66M | 11.46M | 11.46M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | 1.66M | 11.46M | 11.46M |
|
|
|||||
| Total Common Equity | 122.62M | 133.03M | 21.08M | -13.61M | -112.54M |
| Total Preferred Equity | -- | -- | 1.66M | 11.46M | 11.46M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 122.62M | 133.03M | 22.73M | -2.15M | -101.09M |
|
|
|||||